ZURA BIO LIMITED Temporary Equity, Carrying Amount, Attributable to Parent
ZURA BIO LIMITED (ZURA) had Temporary Equity, Carrying Amount, Attributable to Parent of $12.50 million as of 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Equity › Temporary Equity
us-gaap:TemporaryEquityCarryingAmountAttributableToParent · last filed 2024-03-28
- 2022-12-31: Temporary Equity, Carrying Amount, Attributable to Parent $12.50M; Temporary Equity, Carrying Amount, Attributable to Parent as first filed $141.37M.
- 2022-09-30: Temporary Equity, Carrying Amount, Attributable to Parent $140.18M.
- 2022-06-30: Temporary Equity, Carrying Amount, Attributable to Parent $139.50M.
- 2022-03-31: Temporary Equity, Carrying Amount, Attributable to Parent $139.38M.
| Period end | Temporary Equity, Carrying Amount, Attributable to Parent | Temporary Equity, Carrying Amount, Attributable to Parent as first filed |
|---|---|---|
| 2022-12-31 | $12.50M 10-K · filed 2024-03-28 | $141.37M 10-K · filed 2023-03-28 |
| 2022-09-30 | $140.18M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $139.50M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $139.38M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $139.38M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $139.38M 10-Q/A · filed 2022-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |